{"product_id":"ehmt2-antibody-sc-f0379","title":"G9a\/EHMT2 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eG9a, also recognized as Euchromatic histone-lysine N-methyltransferase 2 (EHMT2), belongs to a family of histone lysine methyltransferases, featuring a conserved catalytic SET domain initially identified in Drosophila Su[var]3-9, Enhancer of zeste, and Trithorax proteins. In vitro, recombinant G9a exhibits the capability to mono-, di-, and tri-methylate histone H3 on Lys9 and Lys27. Depending on the literature source, EHMT2 may also be discussed as G9a\/EHMT2 and EHMT2\/G9A.\u003c\/p\u003e\u003cp\u003eReported cellular context includes chromosome and nucleus, which can matter when signal is compared across treatments or changing cell states. Following EHMT2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eEHMT2 is commonly interpreted in the context of epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between chromosome and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003elinks between target behavior and transcriptional or chromatin-state changes\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EHMT2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EHMT2 reflect biology rather than handling. When interpreting EHMT2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep EHMT2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577448309081,"sku":"F0379-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577448341849,"sku":"F0379-100UL","price":319.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577448374617,"sku":"F0379-2X100UL","price":479.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0379-wb.gif?v=1773598396","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/ehmt2-antibody-sc-f0379","provider":"Absource Diagnostics","version":"1.0","type":"link"}